Company intelligence / Profile preview

KenSci

Seattle, WA, USA

Ownership: Private
Employees: ~150
Development stage: Other

Overview

KenSci is a healthcare data science and artificial intelligence company that provides a risk prediction platform to help health systems improve clinical, operational, and financial outcomes. The company's platform uses machine learning to predict risks such as hospital readmissions, sepsis, and length of stay, enabling proactive intervention. KenSci's solutions are designed to integrate with existing electronic health record (EHR) systems to provide real-time insights at the point of care. In 2022, KenSci merged with Alivia Technology and Lumedic to form Advata, a consolidated healthcare analytics company.

Therapeutic areas: CardiovascularNephrologyOtherInfectious Diseases
Modalities: SoftwareArtificial Intelligence
Industry: Digital Health Medical Devices

Partnerships

MicrosoftGE Healthcare

Beyond the preview

Go deeper on KenSci.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KenSci.

Explore the full profile